Condreay, Lynn <br/><br/>
Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary disease.  [electronic resource] 

 -  Respiratory medicine  05 2016 
 - 123-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2016.03.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--therapeutic use<br/>Aged<br/>Benzyl Alcohols--administration & dosage<br/>Bronchodilator Agents--therapeutic use<br/>Chlorobenzenes--administration & dosage<br/>Clinical Trials as Topic<br/>Drug Combinations<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Genome-Wide Association Study<br/>HLA Antigens--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--therapeutic use<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Quinuclidines--administration & dosage<br/>Treatment Outcome<br/>Vital Capacity--drug effects